Author
F. Ni
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2021-2022 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 27 mutual co-author links4 papers
Recent·Most cited
A novel intranasal administration adenoviral vector-based platform for rapid COVID-19 vaccine development
Y. Yuan, X. Gao, F. Ni, W. Xie, W. Fu, G. Zhang, H. Hu, Y. Li, Q. Hu, C. Huang, B. Liu, Y. Liu, Q. Shen, M. Liang
This paper develops a chimpanzee adenovirus-based vaccine against the SARS-CoV-2 Delta variant and shows it induces strong immunity and protects mice from challenge.
bioRxiv · Feb 21, 2022 · PreprintImmunology
The brassinosteroid biosynthesis gene TaD11-2A controls grain size and its elite haplotype improves wheat grain yields
H. Xu, H. Sun, J. Dong, C. Ma, J. Li, Z. Li, Y. Wang, J. Ji, X. Hu, M. Wu, C. Zhao, R. Qin, J. Wu, F. Ni, F. Cui, Y. Wu
This study identifies the wheat gene TaD11-2A, which regulates grain size and root length, and shows its favorable haplotype improves grain yields and salt tolerance in wheat.
bioRxiv · Feb 17, 2022Plant Biology
Short-term instantaneous prophylaxis and efficient treatment against SARS-CoV-2 in hACE2 mice conferred by an intranasal nanobody (Nb22)
X. Wu, Y. Wang, L. Cheng, F. Ni, L. Zhu, S. Ma, B. Huang, M. Ji, H. Hu, Y. Li, S. Xu, H. Shi, L. Liu, W. Nawaz, Q. Hu, , Z. Wu
This paper demonstrates that intranasal nanobody Nb22 provides short-term instantaneous prophylaxis and effective treatment against SARS-CoV-2 in hACE2 mice, with ultrahigh potency and long-lasting retention in the respiratory system.
bioRxiv · Sep 6, 2021Microbiology